Jinlan He

462 total citations
24 papers, 320 citations indexed

About

Jinlan He is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Jinlan He has authored 24 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Jinlan He's work include Head and Neck Cancer Studies (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer-related molecular mechanisms research (4 papers). Jinlan He is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer-related molecular mechanisms research (4 papers). Jinlan He collaborates with scholars based in China and United States. Jinlan He's co-authors include Wenjun Liao, Jiaqi Han, Jianping Yang, Zhixin Qiu, Shuang Zhao, Nianyong Chen, Weimin Li, Hui Guan, Jingjing Wang and Yan He and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Jinlan He

23 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinlan He China 11 160 111 99 96 51 24 320
Yaoxiong Xia China 13 139 0.9× 133 1.2× 99 1.0× 122 1.3× 24 0.5× 39 348
Cédric van Marcke Belgium 12 124 0.8× 165 1.5× 92 0.9× 156 1.6× 30 0.6× 34 370
Yuwei Zhou China 9 155 1.0× 100 0.9× 74 0.7× 156 1.6× 18 0.4× 26 382
Shufen Zhao China 10 170 1.1× 106 1.0× 97 1.0× 83 0.9× 22 0.4× 30 316
Francesca Consoli Italy 9 92 0.6× 128 1.2× 72 0.7× 209 2.2× 55 1.1× 37 367
Franziska Niehr Germany 8 175 1.1× 77 0.7× 56 0.6× 136 1.4× 32 0.6× 10 276
Jiahuai Wen China 10 162 1.0× 164 1.5× 67 0.7× 161 1.7× 15 0.3× 17 380
Bojin Su China 8 300 1.9× 144 1.3× 85 0.9× 101 1.1× 18 0.4× 13 473
Cai‐Jin Lin China 11 60 0.4× 132 1.2× 96 1.0× 152 1.6× 15 0.3× 34 329
Dillip Kumar Muduly India 8 181 1.1× 103 0.9× 49 0.5× 112 1.2× 13 0.3× 47 328

Countries citing papers authored by Jinlan He

Since Specialization
Citations

This map shows the geographic impact of Jinlan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinlan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinlan He more than expected).

Fields of papers citing papers by Jinlan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinlan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinlan He. The network helps show where Jinlan He may publish in the future.

Co-authorship network of co-authors of Jinlan He

This figure shows the co-authorship network connecting the top 25 collaborators of Jinlan He. A scholar is included among the top collaborators of Jinlan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinlan He. Jinlan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yiqi, et al.. (2025). Dihydromyricetin restores mucus hypersecretion in Air–Liquid interface cultures in COPD by targeting the SRC-MAPK signaling pathway. European Journal of Pharmacology. 1000. 177703–177703. 1 indexed citations
2.
He, Jinlan, et al.. (2024). PYCR1 regulates TRAIL‑resistance in non‑small cell lung cancer cells by regulating the redistribution of death receptors. Oncology Letters. 27(5). 216–216. 1 indexed citations
3.
4.
5.
6.
Zhang, Shu, Ni Zeng, Jianping Yang, et al.. (2023). Advancements of radiotherapy for recurrent head and neck cancer in modern era. Radiation Oncology. 18(1). 166–166. 28 indexed citations
7.
8.
9.
Liu, Zijian, Jinlan He, Jiaqi Han, et al.. (2022). m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma. Frontiers in Immunology. 12. 762243–762243. 23 indexed citations
10.
Liao, Wenjun, Jinlan He, Xiangde Luo, et al.. (2022). Automatic Delineation of Gross Tumor Volume Based on Magnetic Resonance Imaging by Performing a Novel Semisupervised Learning Framework in Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 113(4). 893–902. 16 indexed citations
11.
Liu, Zijian, Jinlan He, & Xiaolin Hu. (2022). Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma. Frontiers in Genetics. 13. 975190–975190. 4 indexed citations
12.
Duan, Yifei, et al.. (2021). Characteristics and forecasting of respiratory viral epidemics among children in west China. Medicine. 100(16). e25498–e25498. 7 indexed citations
13.
Liao, Wenjun, Jinlan He, Zijian Liu, et al.. (2021). A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. Radiation Oncology. 16(1). 186–186. 5 indexed citations
14.
15.
Yang, Jianping, et al.. (2020). A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma. International Immunopharmacology. 87. 106821–106821. 25 indexed citations
16.
He, Jinlan, Li Min, Yan He, et al.. (2019). Extracellular vesicles transmitted miR‐31‐5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma. International Journal of Cancer. 146(4). 1052–1063. 61 indexed citations
17.
He, Jinlan, Lei Cai, Ye Chen, et al.. (2018). Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway. Radiotherapy and Oncology. 129(1). 30–37. 12 indexed citations
18.
He, Jinlan, et al.. (2016). Malignant pleural and pericardial effusions and meningeal infiltrates without other metastases in breast cancer: A case report. Molecular and Clinical Oncology. 4(5). 855–858. 2 indexed citations
19.
Xie, Yuxin, et al.. (2014). Recurrent desmoid tumor of the mediastinum: A case report. Oncology Letters. 8(5). 2276–2278. 4 indexed citations
20.
Zhao, Shuang, Jinlan He, Zhixin Qiu, et al.. (2014). Prognostic Value of CD44 Variant exon 6 Expression in Non-Small Cell Lung Cancer: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(16). 6761–6766. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaoxiong Xia Breakdown of academic impact, for papers by Cédric van Marcke Breakdown of academic impact, for papers by Yuwei Zhou Breakdown of academic impact, for papers by Shufen Zhao Breakdown of academic impact, for papers by Francesca Consoli Breakdown of academic impact, for papers by Franziska Niehr Breakdown of academic impact, for papers by Jiahuai Wen Breakdown of academic impact, for papers by Bojin Su Breakdown of academic impact, for papers by Cai‐Jin Lin Breakdown of academic impact, for papers by Dillip Kumar Muduly
Rankless by CCL
2026